Stereoselective synthesis of the Gal‐α‐(1→3)‐Gal‐β‐(1→3)‐GlcNAc trisaccharide: a new ligand for DCAR and Mincle C‐type lectin receptors

Jacopo Tricomi,Mike Aoun,Bingze Xu,Rikard Holmdahl,Barbara Richichi
DOI: https://doi.org/10.1002/cbic.202400026
IF: 3.2
2024-03-21
ChemBioChem
Abstract:In this work, we have discovered that the Gal‐α‐(1→3)‐Gal‐β‐(1→3)‐GlcNAc trisaccharide, a fragment of the B antigen Type‐1, is a new ligand of two C‐type lectin receptors (CLRs) i.e. DCAR and Mincle which are key players in different types of autoimmune diseases. Accordingly, we report here on a straightforward methodology to access pure Gal‐α‐(1→3)‐Gal‐β‐(1→3)‐GlcNAc trisaccharide. A spacer with a terminal primary amine group was included to the reducing end of the GlcNAc residue thus ensuring the further functionalization of the trisaccharide Gal‐α‐(1→3)‐Gal‐β‐(1→3)‐GlcNAc
biochemistry & molecular biology,chemistry, medicinal
What problem does this paper attempt to address?